Federal Cabinet approves multi-billion euro “Health Research Framework Program”. People's diseases will be better researched in the future.
The Federal Ministry of Education and Research (BMBF) plans to invest a total of 5.5 billion euros over the next four years to expand health research in Germany, particularly in the area of so-called common diseases. The corresponding "Framework Program for Health Research" was decided yesterday by the Federal Cabinet. Common diseases include diseases such as dementia, diabetes or cardiovascular diseases such as high blood pressure.
Investments of 5.5 billion planned by 2014 The planned investments in the eight-year “Health Research Framework Program” of 5.5 billion euros between 2011 and 2014 should not only promote research at universities, university clinics, business and other research institutes, but also Federal Research Minister Anette Schavan (CDU) also made it possible to transfer research results into practice more quickly. The money should flow on the one hand into the establishment and expansion of six research centers, and on the other hand into the development of individualized medicine and nutrition and health services research. "We are pursuing the strategy of bringing together the best scientists and thus promoting the rapid transfer of knowledge from the laboratory to practice," said the Federal Research Minister in a recent press release. Schavan added: "The focus is on those diseases that affect most people, the so-called common diseases." In addition, the development of diagnostics and therapeutics should be financially supported and the influence of diet and exercise on the development of diseases should be analyzed in more detail, the minister explained.
Six centers for health research to emerge With the establishment of the six centers for health research, the cooperation of university and non-university scientists is to provide massive support for research and treatment in the most important common diseases, according to the Federal Minister of Research's statement on the current cabinet decision. Two of these research centers - the German Center for Neurodegenerative Diseases (DZNE) in Bonn (2009) and the German Center for Diabetes Research (DZD) in Berlin (2010) - have already been opened. Four further centers for cardiovascular diseases, infectious diseases, cancer and lung diseases are to follow on the basis of the "Health Research Framework Program". In the six German health research centers, academics from universities and non-university institutions will work closely together on basic research as well as clinical application, the research minister said. "With the new types of networking, we are creating better conditions for new, forward-looking research approaches," concluded the Federal Minister of Research.
Pharmaceutical companies also want to make their contribution “The more we research medical topics, the better we can not only treat diseases, but also prevent them. This also takes the pressure off our healthcare system, ”emphasized Annette Schavan in a recent press release on the corresponding cabinet decision. The industry was also benevolent in view of the current decision, but other demands were also made to improve the general conditions. The head of the Association of Researching Pharmaceutical Companies (Vfa), Cornelia Yzer, explained in relation to the new "Framework Program for Health Research" that pharmaceutical companies would be happy to do their part to achieve the increase in the innovative strength of the health care industry that the federal government wanted. However, Germany would then have to "also become more open to innovation", Yzer emphasized and added: "For this we need a network of research, health and economic policies". (fp)
World Diabetes Day: Warning of the Sugar Epidemic
Image: Gerd Altmann / pixelio.de